Results 171 to 180 of about 8,412,464 (305)
Splenic Stiffness Measurement: A New Frontier in the Management of Pediatric Portal Hypertension
Portal Hypertension &Cirrhosis, EarlyView.
Samannay Das, Tamoghna Biswas
wiley +1 more source
Understanding the Type 2 Immunity: An Evolving View Beyond Allergic Diseases
ABSTRACT Type 2 (T2) immunity is classically associated with defense against helminths and environmental threats, from a physiological perspective, and with allergies and eosinophilic inflammatory diseases, in a pathological sense. However, growing evidence reveals that T2 pathways also support other essential homeostatic functions, including tissue ...
Rodrigo Jiménez‐Saiz +22 more
wiley +1 more source
Efficacy and Safety of Octreotide for Gastrointestinal Bleeding Due to Portal Hypertension in Children-A Systematic Review. [PDF]
Kozak A +3 more
europepmc +1 more source
Splenectomy is a safe and effective treatment option in selected patients with haematological disease, despite declining referrals over the last 27 years in the era of targeted therapies. Outcomes are favourable when performed laparoscopically and long‐term follow‐up demonstrates sustained haematologic benefit in surviving patients.
Salil Dutt Barrett +9 more
wiley +1 more source
A Case of Recurrent Refractory Stomal Variceal Bleeding Associated with Oxaliplatin-Induced Portal Hypertension. [PDF]
Sakamoto K +6 more
europepmc +1 more source
This retrospective cohort compared umbilical‐portal‐systemic venous shunts in singleton and twin pregnancies. Type III was the most common subtype in singletons, whereas Type II was the most common in twins. Fetal growth restriction was more frequent in twins, but primary structural anomaly rates were similar.
Yun Zhang +8 more
wiley +1 more source
Portal Vein Thrombosis Risk in Cirrhotic Patients With Portal Hypertension on Beta-Blockers: A Multi-Institutional Cohort Study. [PDF]
Abosheaishaa H +9 more
europepmc +1 more source
Analysis of 4928 normothermic machine perfusion liver transplants reveals that recipient factors, particularly MELD ≥ 35, surgical complexity, ICU status, and functional impairment are stronger predictors of graft failure than donor characteristics, emphasizing the continued importance of clinical judgment in patient selection.
Lauren E. Matevish +9 more
wiley +1 more source

